AstraZeneca Extends Early-Stage Oncology Pipeline
By Business Review Editor
Pharma Deals Review: Vol 2003 Issue 42 (Table of Contents)
Published: 3 Dec-2003
DOI: 10.3833/pdr.v2003.i42.845 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
AstraZeneca entered into a collaborative agreement with Abgenix to discover, develop and commercialize fully monoclonal antibody to treat cancer...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS